Interview: Kyrexa launches £1.5m funding round for revolutionary Rimcazole canine cancer treatment
Dr Clare Knottenbelt, CEO of Kyrexa, discusses how the company is advancing canine cancer treatment with Rimcazole, an…
Browsing Tag